MedPal AI Hits £8.6m Revenue Run Rate…. It’s Just Getting Started

MedPal AI’s founder and CEO reported an annualised revenue run rate of £8.6 million, built from zero in nine months. That figure came from a single record month, and the conversation focused on whether the growth is durable, profitable, and repeatable. The CEO explained that every pound of revenue is recurring — each month starts from the previous month’s base, not from zero — creating a compounding effect. The business has been built with almost no marketing spend until three weeks ago, which the CEO called “incredible.”

The platform and its compounding revenue streams

MedPal AI operates what the CEO calls a “complete health operating system” — one platform that handles prescribing, robotic dispensing, delivery, and bedside administration for care homes, all supported by AI-driven patient tools. The company invested heavily in a distribution centre designed for over 300,000 orders per month; it is currently processing about 50,000 orders, mostly from NHS prescribing. The CEO emphasised that the different revenue streams feed off each other. A private patient coming in for weight loss can nominate MedPal as their NHS provider, bringing in NHS prescriptions alongside private ones. Conversely, existing NHS patients can be offered private prescriptions. The acquisition of EMRX, though not large, completed the system for care homes: MedPal can now track a prescription from the